{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:31:26Z","timestamp":1790652686349,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106141","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T17:55:44Z","timestamp":1409766944000},"page":"e106141","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Multicenter Study of Trimethoprim\/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia"],"prefix":"10.1371","volume":"9","author":[{"given":"Jen-Jia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Eng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yeh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Song","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"ref1","article-title":"Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: A prospective observational study","author":"KY Lee","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"JE Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccm.2013.02.001","article-title":"Pneumocystis pneumonia associated with human immunodeficiency virus","volume":"34","author":"RF Miller","year":"2013","journal-title":"Clin Chest Med"},{"key":"ref4","first-page":"96","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy","volume":"112","author":"LS Bernstein","year":"1975","journal-title":"Can Med Assoc J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/clinids\/4.2.429","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole","volume":"4","author":"DH Lawson","year":"1982","journal-title":"Rev Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"PA Masters","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/jac\/dks283","article-title":"Acute psychosis related to use of trimethoprim\/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study","volume":"67","author":"KY Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/clinids\/4.2.429","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole","volume":"4","author":"DH Lawson","year":"1982","journal-title":"Reviews of Infectious Diseases"},{"key":"ref9","first-page":"175","article-title":"Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome","volume":"10","author":"RR Mainra","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"PA Masters","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","article-title":"A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity","volume":"15","author":"H Jick","year":"1995","journal-title":"Pharmacotherapy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"N Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"E Bjornsson","year":"2005","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"RJ Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"G Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/abio.1997.2379","article-title":"A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles","volume":"253","author":"AC Deitz","year":"1997","journal-title":"Anal Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/pgs.11.122","article-title":"Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes","volume":"13","author":"DW Hein","year":"2012","journal-title":"Pharmacogenomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"C Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"G Danan","year":"1993","journal-title":"Journal of Clinical Epidemiology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2011.02.007","article-title":"Causality assessment methods in drug induced liver injury: strengths and weaknesses","volume":"55","author":"M Garcia-Cortes","year":"2011","journal-title":"J Hepatol"},{"key":"ref21","article-title":"Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events","journal-title":"Division of AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","article-title":"Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia","volume":"171","author":"WT Hughes","year":"1995","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/AAC.35.9.1884","article-title":"Pharmacokinetics and adverse effects of 20-mg\/kg\/day trimethoprim and 100-mg\/kg\/day sulfamethoxazole in healthy adult subjects","volume":"35","author":"RC Stevens","year":"1991","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study","volume":"109","author":"FR Sattler","year":"1988","journal-title":"Annals of Internal Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00002030-199203000-00007","article-title":"Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial","volume":"6","author":"NC Klein","year":"1992","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.106.105858","article-title":"Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450","volume":"319","author":"PM Vyas","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1007\/BF01643200","article-title":"Co-trimoxazole-induced hepatic injury\u2013an analysis of cases with hypersensitivity-like reactions","volume":"15","author":"PA Berg","year":"1987","journal-title":"Infection"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1592\/phco.30.5.539","article-title":"Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient","volume":"30","author":"TL Bell","year":"2010","journal-title":"Pharmacotherapy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1755-8794-5-32","article-title":"Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV\/AIDS patients","volume":"5","author":"D Wang","year":"2012","journal-title":"BMC Med Genomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516993","article-title":"Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus","volume":"25","author":"CL Smith","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00008571-199712000-00009","article-title":"Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations","volume":"7","author":"HG Xie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/clpt.1994.122","article-title":"The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome","volume":"56","author":"BL Lee","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0090-9556(25)06552-3","article-title":"N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes","volume":"23","author":"AE Cribb","year":"1995","journal-title":"Drug Metab lism and Disposition: The Biological Fate of Chemicals"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clpt.2004.06.002","article-title":"The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)","volume":"76","author":"HR Winter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2362.33.s2.6.x","article-title":"Clinical relevance of genetic polymorphisms in the human CYP2C9 gene","volume":"33","author":"UI Schwarz","year":"2003","journal-title":"European Journal of Clinical Investigation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00228-010-0820-7","article-title":"Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9","volume":"66","author":"A Hellden","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s002280000127","article-title":"Effect of fluconazole on plasma fluvastatin and pravastatin concentrations","volume":"56","author":"T Kantola","year":"2000","journal-title":"European Journal of Clinical Pharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0009-9236(96)80011-7","article-title":"Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers","volume":"59","author":"AK Mitra","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/516975","article-title":"Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity","volume":"25","author":"JA Bronstein","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0163-4453(92)91346-D","article-title":"Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge","volume":"24","author":"C Wells","year":"1992","journal-title":"Journal of Infection"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.43.8.1955","article-title":"Safety and tolerability of fluconazole in children","volume":"43","author":"V Novelli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"1","author":"S De Wit","year":"1989","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection","volume":"54","author":"JL Wang","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.2174\/138161205774580804","article-title":"Hepatotoxicity of antiretroviral drugs","volume":"11","author":"N Abrescia","year":"2005","journal-title":"Curr Pharm Des"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2710.2011.01282.x","article-title":"Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity","volume":"37","author":"MM Miljkovic","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0b013e32834ef599","article-title":"From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management","volume":"25","author":"M Lemoine","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/00912700122009728","article-title":"Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors","volume":"41","author":"LL von Moltke","year":"2001","journal-title":"J Clin Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T13:09:35Z","timestamp":1746364175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106141"}},"subtitle":[],"editor":[{"given":"Soren","family":"Gantt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106141","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}